ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,688Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 1448

$1.43M Total Retail Price of All Prescriptions

Rank: 16 out of 1448

569 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 18,348 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ISOSORBIDE MONONITRATE ER 1,243 1,191 1 16
RANEXA 1,107 1,088 10 2 37
CARVEDILOL 840 835 3 1
CLOPIDOGREL 741 716 4 10
DIOVAN 738 728 5 15
PLAVIX 719 708 6 14
AMLODIPINE BESYLATE 630 619 7 2
LOVAZA 617 606 8 39
ATORVASTATIN CALCIUM 605 601 9 4
DILTIAZEM 24HR CD 489 471 10 10 61
SIMVASTATIN 483 483 11 3
ATENOLOL 367 361 12 12
FUROSEMIDE 355 355 13 7
BENICAR 340 338 14 50
CRESTOR 318 318 15 17
DILTIAZEM 24HR ER 305 274 10 16 52
LEVOTHYROXINE SODIUM 295 295 17 21
NITROSTAT 252 238 18 31
DIGOXIN 212 210 19 13
LOSARTAN POTASSIUM 194 188 20 11
PRAVASTATIN SODIUM 190 190 21 20
NITROGLYCERIN PATCH 189 189 22 98
SINGULAIR 188 188 23 91
METOPROLOL SUCCINATE 186 186 24 6
NIFEDIPINE ER 176 175 25 59
METFORMIN HCL 174 173 26 25
ACTONEL 173 173 27 117
SPIRONOLACTONE 170 169 28 24
NEXIUM 166 166 29 49
GLIMEPIRIDE 155 145 30 66
PROPRANOLOL HCL 144 141 31 105
WELCHOL 143 129 32 103
DILTIAZEM ER 140 138 33 78
METOPROLOL TARTRATE 139 139 34 9
DIPYRIDAMOLE 138 126 R 35 302
LIDODERM 137 136 36 81
BISOPROLOL FUMARATE 133 133 37 72
ALLOPURINOL 130 130 38 43
SOTALOL 123 123 39 40
MICARDIS 119 119 40 143
NIASPAN 118 118 41 47
DILTIAZEM HCL 117 117 42 145
ZOLPIDEM TARTRATE 112 102 43 34
VOLTAREN 111 111 44 107
OMEPRAZOLE 105 105 45 23
BYSTOLIC 104 104 46 32
MELOXICAM 103 102 47 73
MONTELUKAST SODIUM 98 98 48 135
EFFIENT 96 95 49 69
POTASSIUM CHLORIDE 93 93 50 19
FLECAINIDE ACETATE 83 83 51 53
VERAPAMIL ER 83 83 51 88
LIPITOR 83 83 51 30
GLYBURIDE-METFORMIN HCL 81 81 R 54 132
DONEPEZIL HCL 76 76 55 68
EVISTA 76 76 55 134
ACTOS 73 73 57 92
TAMSULOSIN HCL 73 73 57 46
ADVAIR DISKUS 72 72 59 74
MEGESTROL ACETATE 70 70 R 60 126
FAMOTIDINE 70 70 60 60
TRILIPIX 68 68 62 86
AMLODIPINE BESYLATE-BENAZEPRIL 68 68 62 67
WARFARIN SODIUM 65 65 64 8
JANUVIA 65 65 64 64
PENTOXIFYLLINE 64 64 66 315
TAZTIA XT 64 64 66 316
TEKTURNA 63 63 68 106
AMIODARONE HCL 62 54 69 22
PATANOL 59 59 70 175
LEVOFLOXACIN 58 58 71 131
DIOVAN HCT 58 55 71 29
HYDRALAZINE HCL 55 55 73 44
ALENDRONATE SODIUM 52 52 74 41
CELEBREX 50 50 75 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.